[Epidemiology of leprosy in Guadeloupe from 1970 to 1984]. 1986

J L Cartel, and J J Gallais, and Y Naudillon, and J G Rémy, and J H Grosset

Analysis of computerized data compiled according to the OMSLEP system in the leprosy control service in Guadeloupe has shown that from 1970 to 1984, 80% of the patients were detected by passive case-finding (symptomatic patients), 10% by active case-finding among the school population and 10% by active case-finding among the house-hold contacts of known patients. During the same period of time, global incidence of new cases of leprosy declined from 24 to 11 per 100,000 inhabitants. The decline was greater for paucibacillary cases (y = -0,94) than for multibacillary cases (y = -0,45), and much greater among persons under 15 years of age (y = -3,22) than among those older ones (y = -0,67). Simultaneously 118 relapses, an annual incidence of 1,3%, were observed among the multibacillary patients previously treated by dapsone monotherapy for five years or more. All cases the biopsies of whom were inoculated for drug sensitivity testing in the mouse foot pad yielded dapsone-resistant M. leprae. The proportions of relapses among the annual sources of infection increased from 16% in 1970 to 47% in 1984. Chemoprophylaxis of relapses among multibacillary patients already treated for more than five years with dapsone monotherapy is one of the priorities for leprosy control in Guadeloupe.

UI MeSH Term Description Entries
D007918 Leprosy A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid. Hansen's Disease,Hansen Disease
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D014900 West Indies Islands lying between southeastern North America and northern South America, enclosing the Caribbean Sea. They comprise the Greater Antilles (CUBA; DOMINICAN REPUBLIC; HAITI; JAMAICA; and PUERTO RICO), the Lesser Antilles (ANTIGUA AND BARBUDA and the other Leeward Islands, BARBADOS; MARTINIQUE and the other Windward Islands, NETHERLANDS ANTILLES; VIRGIN ISLANDS OF THE UNITED STATES, BRITISH VIRGINI ISLANDS, and the islands north of Venezuela which include TRINIDAD AND TOBAGO), and the BAHAMAS. (From Webster's New Geographical Dictionary, 1988, p1330) Caribbean Islands,Cayman Islands,Montserrat,Turks and Caicos Islands

Related Publications

J L Cartel, and J J Gallais, and Y Naudillon, and J G Rémy, and J H Grosset
January 1996, Salud publica de Mexico,
J L Cartel, and J J Gallais, and Y Naudillon, and J G Rémy, and J H Grosset
January 1972, Bulletin de la Societe de pathologie exotique et de ses filiales,
J L Cartel, and J J Gallais, and Y Naudillon, and J G Rémy, and J H Grosset
January 1987, Bulletin de la Societe de pathologie exotique et de ses filiales,
J L Cartel, and J J Gallais, and Y Naudillon, and J G Rémy, and J H Grosset
June 1985, Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau,
J L Cartel, and J J Gallais, and Y Naudillon, and J G Rémy, and J H Grosset
February 2006, Pathologie-biologie,
J L Cartel, and J J Gallais, and Y Naudillon, and J G Rémy, and J H Grosset
March 1987, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
J L Cartel, and J J Gallais, and Y Naudillon, and J G Rémy, and J H Grosset
March 1984, Lancet (London, England),
J L Cartel, and J J Gallais, and Y Naudillon, and J G Rémy, and J H Grosset
March 1987, Obstetrics and gynecology,
J L Cartel, and J J Gallais, and Y Naudillon, and J G Rémy, and J H Grosset
September 1985, Health bulletin,
J L Cartel, and J J Gallais, and Y Naudillon, and J G Rémy, and J H Grosset
January 2005, Presse medicale (Paris, France : 1983),
Copied contents to your clipboard!